CanadaBis Capital (TSXV:CANB) ROE % Adjusted to Book Value : 1.39% (As of Jan. 2024)

View and export this data going back to 2017. Start your Free Trial

What is CanadaBis Capital ROE % Adjusted to Book Value?

CanadaBis Capital's ROE % for the quarter that ended in Jan. 2024 was 5.43%. CanadaBis Capital's PB Ratio for the quarter that ended in Jan. 2024 was 3.90. CanadaBis Capital's ROE % Adjusted to Book Value for the quarter that ended in Jan. 2024 was 1.39%.

CanadaBis Capital ROE % Adjusted to Book Value Historical Data

The historical data trend for CanadaBis Capital's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanadaBis Capital ROE % Adjusted to Book Value Chart

CanadaBis Capital Annual Data

Trend

Nov16

Dec17

Dec18

Jul19

Jul20

Jul21

Jul22

Jul23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-43.41

-21.77

-10.57

15.48

16.27

CanadaBis Capital Quarterly Data
	Mar19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															43.78	15.03	13.78	9.14	1.39

Competitive Comparison of CanadaBis Capital's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CanadaBis Capital's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where CanadaBis Capital's ROE % Adjusted to Book Value falls into.

CanadaBis Capital ROE % Adjusted to Book Value Calculation

CanadaBis Capital's ROE % Adjusted to Book Value for the fiscal year that ended in Jul. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	90.78%	/	5.58
	=	16.27%

CanadaBis Capital's ROE % Adjusted to Book Value for the quarter that ended in Jan. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	5.43%	/	3.90
	=	1.39%

CanadaBis Capital ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of CanadaBis Capital's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

CanadaBis Capital (TSXV:CANB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanadaBis Capital Inc (TSXV:CANB) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

CNADF:USA

Address

PO Box 850, Rocky Mountain House, AB, CAN, T4T 1A6

Website

https://www.canadabis.com

CanadaBis Capital Inc is a vertically-integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extraction and tolling. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premise owned and operated by the Company. Extraction and tolling segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extraction and tolling.

Executives

Garfield Richards

Senior Officer